Kissei Pharmaceutical Net Profit Slides to 5.19 Billion Yen

The Japanese pharmaceutical firm saw its revenue dip slightly to 45.50 billion yen, compared to 45.83 billion yen in the prior year. Operating performance faced significant pressure, resulting in an operating profit of 1.69 billion yen, a stark reversal from the 6.84 billion yen loss recorded in the previous corresponding period. Pretax profit also retreated to 2.92 billion yen from 5.62 billion yen. These results, prepared under Japanese accounting standards, translate to earnings per share of 124.88 yen, down from 186.81 yen reported in 2025.